Lobbying activity

Q2

THE NICKLES GROUP, LLC for NOVO NORDISK, INC.

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $80,000.00 income

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)

View → Q2

DESIMONE CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $30,000.00 income

Pharmacy

View → Q2

IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q2

LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · $30,000.00 income

Medicare/Medicaid, Pharmacy

View → RR

THE KPM GROUP DC LLC for INOZYME PHARMA

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts

Pharmacy

View → 2A

ADVANCED POLICY CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $40,000.00 income

Health Issues

View → Q2

ADVANCED POLICY CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $40,000.00 income

Health Issues

View → Q2

HORIZON GOVERNMENT AFFAIRS for PHRMA

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income

Health Issues

View → Q2

HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate

Health Issues

View → Q2

E3 STRATEGIC CONSULTING GROUP for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION

2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate · $50,000.00 income

Pharmacy

View → Q2

ELITE STRATEGIC SERVICES for CONSERVATIVES FOR PROPERTY RIGHTS

2nd Quarter (Apr 1 - June 30) 2025 · South Carolina · House · Senate · $15,000.00 income

Copyright/Patent/Trademark, Health Issues, Labor Issues/Antitrust/Workplace, Taxation/Internal Revenue Code

View → RR

LMH STRATEGIC SOLUTIONS for PTC THERAPEUTICS, INC.

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey

Taxation/Internal Revenue Code, Medicare/Medicaid, Health Issues

View → 1A

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues

View → Q1

EMD SERONO, INC. for EMD SERONO INC

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Science/Technology, Trade (domestic/foreign), Health Issues, Medicare/Medicaid

View → Q1

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q1

AMGEN, INC. for AMGEN INC

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark

View → Q1

THE MCMANUS GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

THE MCMANUS GROUP for GILEAD SCIENCES, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

PFIZER INC. for PFIZER INC.

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q1

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations

View → Q1

NEUROCRINE BIOSCIENCES, INC for NEUROCRINE BIOSCIENCES, INC

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate

Medicare/Medicaid, Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code

View → Q1

BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Agriculture, Medicare/Medicaid, Tariff (miscellaneous tariff bills), Budget/Appropriations

View → Q1

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q1

COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · $420,000.00 income

Copyright/Patent/Trademark, Health Issues

View → Q1

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Agriculture, Animals, Budget/Appropriations, Chemicals/Chemical Industry

View →